ArticleMicroorganisms2023
Diagnostic and Management of Emphysematous Hepatitis with Emphasis on Biopathology.
Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 7 citations in OpenAlex.
- Fulminant emphysematous hepatitis with pneumoperitoneum: A case report.Radiology case reports · 2026Article
- A rare but lethal hepatic infection: Emphysematous hepatitis - Case report and literature review.Hepatology forum · 2026Article
- Successful Non-surgical Management of Emphysematous Hepatitis During Chemotherapy for Acute Myeloid Leukemia.Cureus · 2025Article
- Septic shock caused by emphysematous hepatitis complicated with intracranial infection.IDCases · 2025Article
- When Gas Replaces the Liver: A Rare Case of Successfully Treated Emphysematous Hepatitis.Case reports in gastrointestinal medicine · 2025Article
- Emphysematous hepatitis: A case report and review of literature.Radiology case reports · 2024Article
- Computed Tomographic Findings in Dogs with Hepatic Bacterial Parenchymal Infection and Abscessation.Animals : an open access journal from MDPI · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Emphysematous hepatitis is a rare infectious disease, which corresponds to the presence of gas in the liver, without collection and after exclusion of vascular origin. This entity belongs to the group of emphysematous infections, whose physiopathology seems to be linked to the presence of unbalanced diabetes and to bacterial fermentation, leading to the production of gas within the liver parenchyma. Very few cases of emphysematous hepatitis have been described in the literature, and most of them had a rapidly fatal course. In this manuscript, we report the case of a 59-year-old man with emphysematous hepatitis due to wild-type
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.